E-LIB Suche - Ergebnisse für: Ramacciotti, Eduardo

1

Primary results of the brazilian registry of atherothrombot..:

de Barros e Silva, Pedro G. M. ; do Nascimento, Charlene Troiani ; Pedrosa, Rodrigo Pinto...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Predictors of bleeding and thrombotic events among patients..:

de Barros e Silva, Pedro Gabriel Melo ; Furtado, Remo H. M. ; de Alcântara Chaud, Mariana Silveira...
Journal of Thrombosis and Thrombolysis. , 2024

Link: https://doi.org/10.1007/..

3

Venous Thromboembolism Risk Models in Hospitalized Medical ..:

Spyropoulos, Alex C. ; Ramacciotti, Eduardo
Research and Practice in Thrombosis and Haemostasis. , 2024

Link: https://doi.org/10.1016/..

4

Biomarkers Profile in Provoked Versus Unprovoked Deep Venou..:

Tavares, Isabela Rodrigues ; Caffaro, Roberto Augusto ; Portugal, Maria Fernanda...
Clinical and Applied Thrombosis/Hemostasis. 30 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

5

Andexanet Alfa Neutralizes the Anticoagulant Effects of Unf..:

Siddiqui, Fakiha ; Hoppensteadt, Debra ; Jeske, Walter...
Clinical and Applied Thrombosis/Hemostasis. 30 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

6

2023 ISTH update of the 2022 ISTH guidelines for antithromb..:

Schulman, Sam ; Arnold, Donald M. ; Bradbury, Charlotte A....
Journal of Thrombosis and Haemostasis. 22 (2024) 6 - p. 1779-1797 , 2024

Link: https://doi.org/10.1016/..

7

Double-edged sword effect of platelets in COVID-19:

Jadali, Zohreh ; Sobreira, Marcone Lima ; Ramacciotti, Eduardo...
Jornal Vascular Brasileiro. 22 (2023) - p. , 2023

Link: https://doi.org/10.1590/..

8

A novel therapeutic vaccine targeting the soluble TNFα rece..:

Iversen, Patrick L. ; Kipshidze, Nicholas ; Kipshidze, Nodar...
Frontiers in Cardiovascular Medicine. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Cost-effectiveness analysis of extended thromboprophylaxis ..:

Carvalho de Oliveira, Caroline Cândida ; Agati, Leandro Barile ; Ribeiro, Camilla Moreira...
The Lancet Regional Health - Americas. 24 (2023) - p. 100543 , 2023

Link: https://doi.org/10.1016/..

10

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Col..:

Bonifácio, Lívia Pimenta ; Ramacciotti, Eduardo ; Agati, Leandro Barile...
Revista da Sociedade Brasileira de Medicina Tropical. 56 (2023) - p. , 2023

Link: https://doi.org/10.1590/..

11

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After ..:

Longo de Oliveira, André Luiz Malavasi ; de Oliveira Pereira, Renata Fernanda ; Agati, Leandro Barile...
Clinical and Applied Thrombosis/Hemostasis. 28 (2022) - p. 107602962211325 , 2022

Link: https://doi.org/10.1177/..

12

ISTHguidelines for antithrombotic treatment inCOVID‐19:

Schulman, Sam ; Sholzberg, Michelle ; Spyropoulos, Alex C....
Journal of Thrombosis and Haemostasis. 20 (2022) 10 - p. 2214-2225 , 2022

Link: https://doi.org/10.1111/..

13

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arte..:

Ramacciotti, Eduardo ; Agati, Leandro Barile ; Volpiani, Giuliano Giova...
Clinical and Applied Thrombosis/Hemostasis. 28 (2022) - p. 107602962110739 , 2022

Link: https://doi.org/10.1177/..

14

Rivaroxaban versus no anticoagulation for post-discharge th..:

Ramacciotti, Eduardo ; Barile Agati, Leandro ; Calderaro, Daniela...
The Lancet. 399 (2022) 10319 - p. 50-59 , 2022

Link: https://doi.org/10.1016/..

15

A Prospective Study Evaluating Patterns of Responses to the..:

Grill, Marcelo Halfen ; Caffaro, Roberto Augusto ; Grill, Thiago Alverez...
Clinical and Applied Thrombosis/Hemostasis. 28 (2022) - p. 107602962211120 , 2022

Link: https://doi.org/10.1177/..